Literature DB >> 23893153

Treatment of pituitary prolactinoma reverses unresponsiveness to PDE5 inhibitor therapy in men with ED and SHPRL.

Tao Jiang, Lei Zheng, Xiao-Ming Su, Jin-Qiang Peng, Dong-Cheng Sun, Quan-Lin Li, Zhi-Wei Zhang, Fa-Peng Wang, Hui Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23893153      PMCID： PMC3854058          DOI： 10.1038/aja.2013.90

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  9 in total

Review 1.  The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.

Authors:  J C Cappelleri; R C Rosen
Journal:  Int J Impot Res       Date:  2005 Jul-Aug       Impact factor: 2.896

2.  [Hormonal etiology in erectile dysfunction].

Authors:  José María Martínez Jabaloyas
Journal:  Arch Esp Urol       Date:  2010-10       Impact factor: 0.436

3.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  Endocrine aspects of male sexual dysfunctions.

Authors:  Jacques Buvat; Mario Maggi; Louis Gooren; Andre T Guay; Joel Kaufman; Abraham Morgentaler; Claude Schulman; Hui Meng Tan; Luiz Otavio Torres; Aksam Yassin; Michael Zitzmann
Journal:  J Sex Med       Date:  2010-04       Impact factor: 3.802

Review 5.  Sexual dysfunction in men and women with endocrine disorders.

Authors:  Shalender Bhasin; Paul Enzlin; Andrea Coviello; Rosemary Basson
Journal:  Lancet       Date:  2007-02-17       Impact factor: 79.321

Review 6.  Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA).

Authors:  Mario Maggi; Jaques Buvat; Giovanni Corona; André Guay; Luiz Otavio Torres
Journal:  J Sex Med       Date:  2012-04-23       Impact factor: 3.802

7.  Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction.

Authors:  Giovanni Corona; Edoardo Mannucci; Emmanuele A Jannini; Francesco Lotti; Valdo Ricca; Matteo Monami; Valentina Boddi; Elisa Bandini; Giancarlo Balercia; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2009-02-10       Impact factor: 3.802

8.  Effect of hyperprolactinemia in male patients consulting for sexual dysfunction.

Authors:  Giovanni Corona; Edoardo Mannucci; Alessandra D Fisher; Francesco Lotti; Valdo Ricca; Giancarlo Balercia; Luisa Petrone; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2007-07-26       Impact factor: 3.802

9.  Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.

Authors:  Rama Walia; Anil Bhansali; Pinaki Dutta; Niranjan Khandelwal; Ravinder Sialy; Sanjay Bhadada
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375
  9 in total
  1 in total

1.  FROM ERECTILE DYSFUNCTION TO BRAIN SUBEPENDYMOMA: A CASE REPORT.

Authors:  Tatjana Bačun; Aleksandar Kibel; Dunja Degmečić; Roman Pavić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.